Contact
About Us
Management
Company Profile
Pharma Company
Egis World
Egis History
Awards and Prizes
CSR - Corporate Social Responsibility
Activities
Research & Development
- Development of active ingredients
- Finished Product Development
Finished Product Manufacturing
Manufacturing Active Substances
Biosimilar Products
Packaging
Sales and Marketing
Licensing activities
Products
Magazine
Career
A place to work
Interactive
Websites in other countries
Armenia
Azerbaijan
Belarus
Bulgaria
Czech Republic
Georgia
Hungary
Kazakhstan
Latvia
Lithuania
Moldova
Poland
Romania
Russia
Slovakia
Ukraine
Uzbekistan
Vietnam
International Egis Website
Home
About Us
Egis History
Websites in other countries
Hungary
International Egis Website
Home
About Us
Management
Company Profile
Pharma Company
Egis World
Egis History
Awards and Prizes
CSR - Corporate Social Responsibility
Activities
Research & Development
- Development of active ingredients
- Finished Product Development
Finished Product Manufacturing
Manufacturing Active Substances
Biosimilar Products
Packaging
Sales and Marketing
Licensing activities
Products
Magazine
Career
A place to work
Interactive
Contact
Egis History
The most important milestones in the history of Egis.
1913
Establishment of the company
1926
Presence at the International Humanitarian Exhibition
1933
Opening our first research laboratory in Budapest
1937
Ronin: first heterocyclic sulfonamide drug
1940
Construction and modernization
1950
EGYT (predecessor of Egis) established
1954
Expanding
1973
New production site in Körmend, Hungary
1985
Name changed to Egis
1994
Egis shares were introduced to the Hungarian Stock Exchange
1995
Servier acquires 51% of Egis
2006
New strategy
2009
New tablet production plant
2013
Market Launch of Biosimilar Products
2015
A market leader biosimilar product, first product portfolio acquisition
2018
A market leader biosimilar product, first successful acquisition
Related articles from Egis Magazine
Innovation
New Unit Inaugurated at Egis’s Körmend Plant
More
Corporate Social Responsibility
Congratulations, Egis Russia! – CSR Campaign Wins Prestigious Award
More
Health
Egis Strengthens European Presence in the Biosimilar Area
More
Submit
Submit
We use cookies to operate our website, to improve your experience and to monitor the activities on the website.
I accept
Cookie management policy
Your browser is out of date. Please, use an updated version!
Chrome
||
Firefox